Calendar of CURE/Yale BioHaven seminars for Fall 2010 now available. more
9/14
8:45 am - 6:00 pm

Ubifrance, the French Agency for international business development, cordially invites CURE members to this year's second French Biotech Tour, which aims to connect French and American Biotech companies specialized in neuroscience, inflammation, and auto-immune diseases. Philadelphia, PA. more
9/16
6:00 pm - 7:30 pm

CURE/Yale BioHaven presents Al Mann: 'Creating a successful medical device enterprise.' Hope Auditorium, Yale University, 315 Cedar Street, New Haven. more
10/5
Deadline for nominations for the Lemelson-MIT prize, awarded to an outstanding mid-career inventor who has developed a patented product or process of significant value to society. more
10/27
4:00 pm - 6:00 pm

CURE/Yale BioHaven presents Cobalt Therapeutics. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
11/18
4:00 pm - 6:00 pm

CURE/Yale BioHaven presents Biodel Inc. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
12/7
5:30 pm - 7:30 pm

CURE Holiday Party. Café George, 300 George Street, New Haven. Watch for details.


Fabiani & Company
1101 Pennsylvania Avenue, NW
Suite 700
Washington, DC 20004

Phone: 202-756-4994
Fax: 202-756-7554
Website: http://www.fabiani-co.com

General Information
In the fast-paced universe of start-ups and private capital, federal government partnerships and funding may be overlooked as potential strategies to attract private investment and advance the commercialization of pharmaceutical and medical device products. Such partnerships and opportunities provide an alternative, non-dilutive funding mechanism for companies with new technologies that fulfill a national and international need.

The selection of companies that become recipients of federal funding depends on a complex weave of factors including the ability of the company’s technology to serve a need, the strategic location of research/manufacturing facilities, the selection of academic partners, and the political profile of the organization and its products among public officials.

Fabiani & Company’s Life Sciences team is dedicated to facilitating strategic government and non-government research partnerships for its Life Sciences clients.

Over the past five years, Fabiani & Company has successfully helped to increase the value of its clients’ companies through:

? Funding to support basic research, clinical trials and government procurement;

? Research partnerships with government laboratories, influential non-government organizations and other companies;

? Government validation of novel technologies and clinical procedural protocols; and

? Targeted advocacy for legislative action that will benefit our client companies in the life sciences sector.

Other Information
Ownership: Private
World Employees: 15

Back